Seroatlas · Human Serome Atlas

CLDN10

Claudin-10

Also known as: CLD10_HUMAN, CPETRL3, OSP-L

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P78369
Gene
CLDN10
Ensembl
ENSG00000134873
Chromosome
13
Canonical length
228 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The expression level of this gene is associated with recurrence of primary hepatocellular carcinoma. Six alternatively spliced transcript variants encoding different isoforms have been reported, but the transcript sequences of some variants are not determined.[provided by RefSeq, Jun 2010]

Canonical amino-acid sequenceUniProt

228 residues, UniProt reviewed canonical sequence.

>P78369|CLDN10
     1  MASTASEIIA FMVSISGWVL VSSTLPTDYW KVSTIDGTVI TTATYWANLW KACVTDSTGV
    61  SNCKDFPSML ALDGYIQACR GLMIAAVSLG FFGSIFALFG MKCTKVGGSD KAKAKIACLA
   121  GIVFILSGLC SMTGCSLYAN KITTEFFDPL FVEQKYELGA ALFIGWAGAS LCIIGGVIFC
   181  FSISDNNKTP RYTYNGATSV MSSRTKYHGG EDFKTTNPSK QFDKNAYV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CLDN10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
4
Mean surface accessibility (rSASA)
0.37
Highest tissue expression
112 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 112 nTPM
  • salivary gland: 81 nTPM
  • kidney: 73 nTPM
  • amygdala: 38 nTPM
  • cerebral cortex: 34 nTPM
  • cervix: 29 nTPM

Single-cell type

  • endometrial secretory cells: 851 nCPM
  • proximal tubule cells: 549 nCPM
  • pancreatic duct cells: 480 nCPM
  • lacrimal acinar cells: 374 nCPM
  • salivary acinar cells: 352 nCPM
  • oocytes: 322 nCPM

Immune cell

  • neutrophil: 4.1 nTPM
  • eosinophil: 1.3 nTPM
  • basophil: 0.4 nTPM
  • memory B-cell: 0.3 nTPM
  • plasmacytoid DC: 0.1 nTPM
  • classical monocyte: 0 nTPM

Brain region

  • cerebral cortex: 31 nTPM
  • amygdala: 21 nTPM
  • hippocampal formation: 19 nTPM
  • basal ganglia: 16 nTPM
  • hypothalamus: 16 nTPM
  • thalamus: 16 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CLDN10.

Disease | AllUniProt

Conditions CLDN10 is implicated in, by any mechanism.

Disease | GeneticClinVar

7 pathogenic / likely-pathogenic of 53 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.22
gnomAD pLI
0
gnomAD missense Z
0.54
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CLDN10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CLDN10 as an antibody target. Whether an autoantibody or antibody against CLDN10 could matter depends on whether native CLDN10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CLDN10 is annotated at the cell surface, where native CLDN10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label CLDN10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CLDN10. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...